S. Hayley

Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs

Brian J. Christmas, Christine I. Rafie, Alexander C. Hopkins et al. · Cancer Immunology Research · 2018 · 210 citations

A CD40 Agonist and PD-1 Antagonist Antibody Reprogram the Microenvironment of Nonimmunogenic Tumors to Allow T-cell–Mediated Anticancer Activity

S. Hayley, Bibhav Poudel, Evanthia T. Roussos Torres et al. · Cancer Immunology Research · 2019 · 124 citations

T-cell–mediated Anticancer Activity, Antagonist Mabs, Immunology +23

All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo

S. Hayley, Sarah Greenblatt, Courtney M. Shirley et al. · Blood · 2016 · 54 citations · Full text

Adaptation to TKI Treatment Reactivates ERK Signaling in Tyrosine Kinase–Driven Leukemias and Other Malignancies

J. Kyle Bruner, S. Hayley, Li Li et al. · Cancer Research · 2017 · 43 citations · Full text

FLT3/D835Y mutation knock-in mice display less aggressive disease compared with FLT3/internal tandem duplication (ITD) mice

Emily Bailey, Li Li, Amy S. Duffield et al. · Proceedings of the National Academy of Sciences · 2013 · 32 citations · Full text